TCMBANKIN001434 |
Cadina-9,11(12)-diene |
cadina-9,11(12)-diene |
|
204.39 |
CC1CCC2C(C1)C(CC=C2C)C(=C)C |
TCMBANKIN007245 |
gibberellin A20 |
CHEBI:58526; 7alpha-hydroxy-1beta-methyl-8-methylidene-13-oxo-4a,1alpha-epoxymethano-4aalpha,4bbeta-gibbane-10beta-carboxylate; gibberellin a20; (1R,2R,5S,8S,9S,10R,11R)-5-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1(5,8).0(1,10).0(2,8)]heptadecane-9-carboxylate; gibberellin a 20; gibberellin A20(1-) |
C19H24O5 |
332.39 |
CC12CCCC3(C1C(C45C3CCC(C4)(C(=C)C5)O)C(=O)[O-])OC2=O |
TCMBANKIN009635 |
xylopine |
|
C18H17NO3 |
295.3 g/mol |
COC1=CC2=C(C=C1)C3=C4C(C2)NCCC4=CC5=C3OCO5 |
TCMBANKIN016146 |
cadaverine |
AC1NS0M3; pentane-1,5-diamine hydrochloride; NSC-5862; Pentamethylenediamine dihydrochloride; NSC5862; Cadaverine Hydrochloride; SCHEMBL344248 |
C5H14N2 |
102.18 g/mol |
C(CCN)CCN |
TCMBANKIN020151 |
l-homoserine |
KB-211151; TC-152476; DTXSID00659274; (R)-3-AMINO-4-HYDROXYBUTYRIC ACID HYDROCHLORIDE; I04-1166; 123053-31-6; L-Homoserine--hydrogen chloride (1/1); FT-0605337; l-beta-homoserine hcl; H72H151; (s)-homoserinehcl; l-beta-homoserine hydrochloride; (S)-2-Amino-4-hydroxybutanoic acid hydrochloride; CTK8B9962; ANW-63731; AKOS015892796; BG00903522; PubChem11050; AK-72527; h-beta-homoser-oh hcl; (S)-Homoserine hydrochloride; h-ser-(c*ch2)oh 2cl; A-8355; L-Homoserine hydrochloride; AX8220589 |
C4H10ClNO3 |
155.58 g/mol |
C(CO)C(C(=O)O)N.Cl |
TCMBANKIN021960 |
Pisatin |
C10516; MEGxp0_001256; 6H-(1,3)Dioxolo(5,6)benzofuro(3,2-c)(1)benzopyran-6a(12aH)-ol, 3-methoxy-, (6aR-cis)-; 469-01-2; pisatin |
C17H14O6 |
314.29 |
COC1=CC2=C(C=C1)C3C(CO2)(C4=CC5=C(C=C4O3)OCO5)O |
TCMBANKIN022518 |
noradrenaline |
l-Norepinephrine bitartrate; 33404-26-1; l-Arterenol d-bitartrate; Norepinephrine hydrogen tartrate; 350-25-4; Benzyl alcohol, alpha-(aminomethyl)-3,4-dihydroxy-, (-)-, tartrate (1:1) (salt); API0007150; 1,2-Benzenediol, 4-((1R)-2-amino-1-hydroxyethyl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt); 341N180; L(+)-TARTARIC ACID; NOREPINEPHRINE; Noradrenalin bitartrate, l-; Arterenol bitartrate; Noradrenaline acid tartrate; MolPort-029-943-999; Norartrinal bitartrate; Levarterenol; ZW81GF408B; Norepinephrine bitartrate anhydrous; L-Noradrenaline bitartrate; 4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol (L-(+))-bitartrate salt; AKOS007930222; Noradrenaline, tartrate (1:1); Norepinephrine tartrate; 73-98-3; Noradrenaline bitartrate; Noradrenaline tartrate; l-Noradrenaline tartrate; UNII-ZW81GF408B; C8H11NO3.C4H6O6; (-)-Norepinephrine bitartrate; (-)-Noradrenaline (+)-bitartrate; BG01031160; 51-40-1; 2477-42-1; Levonorepinephrine; 2595AH; l-Noradrenaline d-bitartrate; Noradrenaline hydrogen tartrate; HMS2089E22; (-)-R-Norepinephrine bitartrate; NSC 169106; 51-41-2 (Parent); API0003624; norepinephrine; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1); l-Arterenol bitartrate; Levarterenol bitartrate; Noradrenalin bitartrate; L-(-)-Noradrenaline (+)-bitartrate salt monohydrate; BENZYL ALCOHOL, alpha-(AMINOMETHYL)-3,4-DIHYDROXY-, (-)-, TARTRATE (1:1); 24868-01-7; 893-91-4; EINECS 200-095-0 |
C8H12NO3+ |
170.19 g/mol |
C1=CC(=C(C=C1C(C[NH3+])O)O)O |
TCMBANKIN022617 |
Xenognosin B |
CHEBI:17678; 7-hydroxy-3-(2-hydroxy-4-methoxyphenyl)-4-chromenone; 7-hydroxy-3-(2-hydroxy-4-methoxy-phenyl)chromone; 2'-Hydroxyformononetin; 2'-Hydroformononetin; 7-hydroxy-3-(2-hydroxy-4-methoxyphenyl)-4H-chromen-4-one; C02920; 7-hydroxy-3-(2-hydroxy-4-methoxyphenyl)chromen-4-one; 7-hydroxy-3-(2-hydroxy-4-methoxy-phenyl)chromen-4-one; 1890-99-9; xenognosin b |
C16H12O5 |
284.26 |
COC1=CC(=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)O)O |
TCMBANKIN023589 |
norarmepavine |
L-(-)-N-norarmepavine; ZINC24717722; SMR000156290; 4-[[(1S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]phenol; BDBM50292465; CHEMBL453038; AC1OE5L2; Norarmepavine; HMS2198P24; MLS000575014 |
C18H21NO3 |
299.4 g/mol |
COC1=C(C=C2C(NCCC2=C1)CC3=CC=C(C=C3)O)OC |
TCMBANKIN024097 |
hydroxyhopane |
|
C30H52O |
428.7 g/mol |
CC1(CCCC2(C1CCC3(C2CCC4C3(CCC5C4(CCC5C(C)(C)O)C)C)C)C)C |
TCMBANKIN029584 |
sym-homospermidine |
N-(4-azaniumylbutyl)butane-1,4-bis(aminium); CHEBI:57811; sym-homospermidinium(3+); sym-homospermidinium trication |
C8H21N3 |
159.27 g/mol |
C(CCNCCCCN)CN |
TCMBANKIN032158 |
m-xylohydroquinone |
|
C8H10O2 |
138.16 g/mol |
CC1=CC(=CC(=C1O)C)O |
TCMBANKIN032645 |
vicine |
|
C10H16N4O7 |
304.26 g/mol |
C(C1C(C(C(C(O1)OC2=C(N=C(NC2=O)N)N)O)O)O)O |
TCMBANKIN032830 |
vignafuran |
|
C16H14O4 |
270.28 g/mol |
COC1=CC2=C(C=C1)C=C(O2)C3=C(C=C(C=C3)O)OC |
TCMBANKIN033688 |
abscisicacid |
abscisic acid |
C15H20O4 |
264.32 g/mol |
CC1=CC(=O)CC(C1(C=CC(=CC(=O)O)C)O)(C)C |
TCMBANKIN040625 |
pisumflavonoside i |
|
C42H46O24 |
934.8 g/mol |
C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3C(C(C(OC3OC4C(C(C(OC4OC5=C(OC6=CC(=CC(=C6C5=O)O)O)C7=CC(=C(C=C7)O)O)CO)O)O)CO)O)O)O)O)O)O |
TCMBANKIN041371 |
Fumaricine |
(1R,8'S)-6,7-dimethoxy-2-methyl-spiro[3,4-dihydroisoquinoline-1,7'-6,8-dihydrocyclopenta[g][1,3]benzodioxole]-8'-ol; Fumaricin; C09444; (1R,8'S)-6,7-dimethoxy-2-methylspiro[3,4-dihydroisoquinoline-1,7'-6,8-dihydrocyclopenta[g][1,3]benzodioxole]-8'-ol; BRD-A87196087-001-01-3; O-Methylfumarophycinol; Spiro[7H-indeno[4,5-d]-1,3-dioxole-7,1'(2'H)-isoquinolin]-8-ol, 3',4',6,8-tetrahydro-6',7'-dimethoxy-2'-methyl-, trans-(-)-; 24181-77-9; 6',7'-DIMETHOXY-2'-METHYL-3',4',6,8-TETRAHYDRO-2H-SPIRO[INDENO[4,5-D][1,3]DIOXOLE-7,1'-ISOQUINOLIN]-8-OL; (1R,8'S)-6,7-dimethoxy-2-methyl-8'-spiro[3,4-dihydroisoquinoline-1,7'-6,8-dihydrocyclopenta[g][1,3]benzodioxole]ol; MolPort-005-945-964; AC1LD0NJ; Dihydroparfumidine; QDNMFIYGVRUVCE-UHFFFAOYSA-N; 6,7-dimethoxy-2-methylspiro[3,4-dihydroisoquinoline-1,7'-6,8-dihydrocyclopenta[g][1,3]benzodioxole]-8'-ol; ACon1_001324; fumaricine; Spiro[7H-indeno[4,5-d]-1,3-dioxole-7,1'(2'H)-isoquinolin]-8-ol, 3',4',6,8-tetrahydro-6',7'-dimethoxy-2'-methyl-, (7S-trans)- |
C21H23NO5 |
369.411 |
C([H])([H])([H])Oc1c([H])c(C([H])([H])C([H])([H])N(C([H])([H])[H])[C@@]23C([H])([H])c(c([H])c([H])c(OC([H])([H])O4)c45)c5[C@@]2(O[H])[H])c3c([H])c1OC([H])([H])[H] |
TCMBANKIN045005 |
Sayaendoside |
|
|
416.4 g/mol |
|
TCMBANKIN045747 |
kaempferol-3-sophorotrioside |
|
C33H40O21 |
772.7 g/mol |
C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)O |
TCMBANKIN046023 |
7alpha,21S,25-Trihydroxy-3beta-acetoxy-21S,23R-epoxy-9(11)-en-dammarane |
[(3S,8S,10S)-7-hydroxy-17-[(2S,5R)-2-hydroxy-5-(2-hydroxy-2-methylpropyl)oxolan-3-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,12,13,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; AC1NT14F; 7α,21s,25-trihydroxy-3β-acetoxy-21s,23r-epoxy-9(11)-en-dammarane; 7alpha,21s,25-trihydroxy-3beta-acetoxy-21s,23r-epoxy-9(11)-en-dammarane |
C32H52O6 |
532.84 |
C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(=C([H])C([H])([H])[C@]([H])([C@@]([H])([C@]2([H])[C@@]([H])(O[H])O[C@@]([H])(C([H])([H])C(O[H])(C([H])([H])[H])C([H])([H])[H])C2([H])[H])C([H])([H])C3([H]
)[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])[C@]([H])(O[H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])OC(=O)C([H])([H])[H] |
TCMBANKIN047408 |
Pisumionoside |
|
|
404.5 g/mol |
|
TCMBANKIN049040 |
quercetin-3-sophorotrioside |
|
C33H40O22 |
788.7 g/mol |
C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)O)O |
TCMBANKIN050320 |
pisumflavonoside ii |
|
C48H56O29 |
1096.9 g/mol |
C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3C(C(C(OC3OC4C(C(C(OC4OC5=C(OC6=CC(=CC(=C6C5=O)O)OC7C(C(C(C(O7)CO)O)O)O)C8=CC(=C(C=C8)O)O)CO)O)O)CO)O)O)O)O)O)O |
TCMBANKIN057915 |
FUM |
U-1149; 110-17-8; 2-Butenedioic acid (E)-; 4-02-00-02202 (Beilstein Handbook Reference); FC 33; Kyselina fumarova; maleic acid; Fumarsaeure; 2-Butenedioic acid (2E)-; 240745_ALDRICH; 2-Butenedioic acid, (E)-; WLN: QV1U1VQ-T; Lichenic acid; LS-500; NSC2752; AIDS-008707; CCRIS 1039; 03761_FLUKA; Lichenic acid (VAN); Caswell No. 465E; W248800_ALDRICH; 2-butenedioic acid, (2E)-; (2E)-2-butenedioic acid; 6915-18-0; Boletic acid; EPA Pesticide Chemical Code 051201; FEMA No. 2488; HSDB 710; Fumaric acid (NF); NCIOpen2_003792; Tumaric acid; 1,2-Ethenedicarboxylic acid, trans-; CHEBI:18012; trans-Butenedioic acid; trans-1,2-Ethylenedicarboxylic acid; FC 33 (acid); fumaric acid; 2-Butenedioic acid; C00122; MALEATE; Allomalenic acid; 110-16-7; AIDS008707; trans-2-Butenedioic acid; AI3-24236; 623158-97-4; But-2-enedioic acid; D02308; NCI60_002239; 1,2-Ethylenedicarboxylic acid, (E); FEMA Number 2488; F8509_SIGMA; NCGC00091192-01; NSC-2752; trans-but-2-enedioic acid; Butenedioic acid, (E)-; Usaf ek-p-583; E-2-Butenedioic acid; BRN 0605763; EINECS 203-743-0; (2E)-but-2-enedioic acid; 2-Butenedioic acid (2E)- (9CI); (E)-2-butenedioic acid; nchembio.2007.47-comp1; Kyselina fumarova [Czech]; BUTENE-1,4-DIOIC ACID; Allomaleic acid; NCIOpen2_004870; Fumaric acid (8CI); CHEBI:22958; cis-butenedioic acid; 2-(E)-Butenedioic acid; MAE; fumaric acid; maiyenic acid; Maleic anhydride, mono(castor oil) ester; Maleic acid [NA2215] [Corrosive]; H2male; AIDS-025527; 2-Butenedioic acid (2Z)-, monocastor oil alkyl esters; InChI=1/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1; CCRIS 1115; 2-Butenedioic acid, (Z)-; 2-Butenedioic acid (Z)- (9CI); 44742-89-4; NCGC00090970-01; (Z)-butenedioic acid; 2-Butenedioic acid (Z)-; 2-butenedioic acid, (2Z)-; Kyselina maleinova [Czech]; (Z)-2-BUTENEDIOIC ACID; cis-but-2-enedioic acid; 2-Butenedioic acid (2Z)- (9CI); ST5213949; WLN: QV1U1VQ-C; Maleic acid (8CI); NSC 25940; 1,2-Ethylenedicarboxylic acid, (Z); 2-Butenedioic acid (2Z)-; (2Z)-but-2-enedioic acid; AI3-01002; 4-02-00-02199 (Beilstein Handbook Reference); 63189_FLUKA; CHEBI:18300; Malezid CM; NSC25940; NA2215; 10237-70-4; AIDS025527; cis-2-Butenedioic acid; EINECS 203-742-5; Maleinic acid; C01384; Malenic acid; HSDB 666; Scotchbond Multipurpose Etchant; BRN 0605762; M0375_SIAL; cis-1,2-Ethylenedicarboxylic acid; Maleic acid [NA2215] [Corrosive]; Butenedioic acid, (Z)-; 68307-91-5; but-2-enoic acid; methanoic acid; A802157; fumaricacid; 2-butenoic acid; formic acid |
C4H4O4 |
116.07 |
C(=CC(=O)O)C(=O)O |
TCMBANKIN057981 |
(+)-gamma-hydroxy-l-homoarginine |
(+)-γ-hydroxy-l-homoarginine |
C7H16N4O3 |
204.23 g/mol |
C(CN=C(N)N)C(CC(C(=O)O)N)O |
TCMBANKIN058004 |
trigonelline |
Prestwick_70; N-Methylnicotinic acid betaine hydrochloride; 1-methyl-3-pyridin-1-iumcarboxylate hydrochloride; MFCD00077250; SCHEMBL468365; A833196; trigonelline ; trigonelline HCl; 1-methylpyridin-1-ium-3-carboxylate hydrochloride; AC1O4WFS; 1-Methylpyridinium-3-carboxylate hydrochloride; T-6500; CHEMBL489961; trigonellin; gynesine; trigonelline |
C7H7NO2 |
137.14 g/mol |
C[N+]1=CC=CC(=C1)C(=O)[O-] |
TCMBANKIN059275 |
propane-2-thiol |
2-propanethiol |
C3H8S |
76.16 g/mol |
CC(C)S |
TCMBANKIN060063 |
gibberellin a3 |
|
C19H22O6 |
346.4 g/mol |
CC12C(C=CC3(C1C(C45C3CCC(C4)(C(=C)C5)O)C(=O)O)OC2=O)O |
TCMBANKIN061223 |
1-propanethiol |
|
C3H8S |
76.16 g/mol |
CCCS |
TCMBANKIN061505 |
l-planinin |
kobusin; ACon1_001273; MEGxp0_001295; 5-[(1S,3aR,4S,6aR)-4-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan-1-yl]-1,3-benzodioxole; kobusin; 36150-23-9; fargesin; demethoxyaschantin |
C21H22O6 |
370.4 g/mol |
COC1=C(C=C(C=C1)C2C3COC(C3CO2)C4=CC5=C(C=C4)OCO5)OC |
TCMBANKIN061551 |
norarmepavine |
n-norarmepavine; L-(-)-N-norarmepavine; ZINC24717722; SMR000156290; 4-[[(1S)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]phenol; BDBM50292465; CHEMBL453038; AC1OE5L2; Norarmepavine; HMS2198P24; MLS000575014 |
C18H21NO3 |
299.4 g/mol |
COC1=C(C=C2C(NCCC2=C1)CC3=CC=C(C=C3)O)OC |
TCMBANKIN061639 |
xenognosin a |
xenognosin |
C16H16O3 |
256.3 g/mol |
COC1=C(C=CC(=C1)O)CC=CC2=CC=C(C=C2)O |